AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 96 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $131,000 | -14.9% | 56,944 | +75.6% | 0.01% | -52.6% |
| Q4 2021 | $154,000 | -47.4% | 32,424 | -11.9% | 0.02% | -51.3% |
| Q3 2021 | $293,000 | +1.4% | 36,804 | -11.3% | 0.04% | -59.8% |
| Q2 2021 | $289,000 | -45.4% | 41,500 | -37.9% | 0.10% | -42.6% |
| Q1 2021 | $529,000 | -35.2% | 66,820 | -35.6% | 0.17% | -27.5% |
| Q4 2020 | $816,000 | +6.5% | 103,700 | -4.0% | 0.23% | -4.1% |
| Q3 2020 | $766,000 | +325.6% | 108,050 | +361.9% | 0.24% | +262.7% |
| Q3 2019 | $180,000 | +19.2% | 23,390 | +6.0% | 0.07% | +19.6% |
| Q2 2019 | $151,000 | +2.0% | 22,060 | +20.3% | 0.06% | -34.1% |
| Q1 2019 | $148,000 | -22.9% | 18,343 | -28.6% | 0.08% | +57.4% |
| Q4 2018 | $192,000 | – | 25,676 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |